Fuse Biotherapeutics
Los Angeles, US · Founded 2021 · Delaware corporation
Biotech
Founders & leadership
YW
Yuanheng Wang LiangDirector
JT
Jeffrey TakimotoExecutive Officer
BR
Brian RabinovichExecutive Officer, Director
PS
Paul SongExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$8.2MraisedNov 2021 · 8 investors · PharmaceuticalsRule 506(b)
Officers, directors & promoters on the filing
- Yuanheng Wang LiangDirector
- Jeffrey TakimotoExecutive Officer
- Brian RabinovichExecutive Officer, Director
- Paul SongExecutive Officer, Director
- Offering amount
- $9.6M
- Amount sold
- $8.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.